Literature DB >> 3003778

Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

S E File, S Pellow.   

Abstract

The imidazodiazepine Ro 15-1788 is a benzodiazepine receptor antagonist that was initially reported to be lacking in intrinsic activity in a variety of test situations in which benzodiazepine-like effects can be identified. However, many recent studies have shown that this compound does indeed have intrinsic activity in a variety of behavioural, neurological, electrophysiological and biochemical preparations in both animals and man. The purpose of the present review is firstly to describe these intrinsic actions, and secondly to consider to what extent these intrinsic actions of Ro 15-1788 have implications for current concepts of the functioning of the benzodiazepine receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003778     DOI: 10.1007/bf00310505

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  105 in total

Review 1.  Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors.

Authors:  S J Cooper; L B Estall
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

2.  Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by Ro 15-1788.

Authors:  P Mormede; R Dantzer; A Perio
Journal:  Pharmacol Biochem Behav       Date:  1984-12       Impact factor: 3.533

3.  Benzodiazepine receptors: differential interaction of benzodiazepine agonists and antagonists after photoaffinity labeling with flunitrazepam.

Authors:  H Möhler
Journal:  Eur J Pharmacol       Date:  1982-06-04       Impact factor: 4.432

4.  Proconvulsant action of CGS 8216.

Authors:  S E File
Journal:  Neurosci Lett       Date:  1983-03-14       Impact factor: 3.046

5.  The anticonvulsant effect of the benzodiazepine antagonist, Ro 15-1788: an EEG study in 4 cases.

Authors:  G Scollo-Lavizzari
Journal:  Eur Neurol       Date:  1984       Impact factor: 1.710

6.  On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain.

Authors:  S E File; A R Green; D J Nutt; N D Vincent
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat.

Authors:  M D Schechter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1984       Impact factor: 5.067

8.  Enhancement of saline consumption by chlordiazepoxide in thirsty rats: antagonism by Ro15-1788.

Authors:  S Turkish; S J Cooper
Journal:  Pharmacol Biochem Behav       Date:  1984-06       Impact factor: 3.533

9.  The effects of benzodiazepine agonists, inverse agonists and Ro 15-1788 on the responses of the superior cervical ganglion to GABA in vitro.

Authors:  H J Little
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

10.  Isoniazid-induced convulsions in rats: effects of Ro 15-1788 and beta-CCE.

Authors:  L Pieri; P Biry
Journal:  Eur J Pharmacol       Date:  1985-06-19       Impact factor: 4.432

View more
  61 in total

1.  Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.

Authors:  V Gentil; S Tavares; C Gorenstein; C Bello; L Mathias; G Gronich; J Singer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93,426: preliminary observations on psychotropic activity.

Authors:  T Duka; D N Stephens; W Krause; R Dorow
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.

Authors:  S E File; J Dingemanse; H L Friedman; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 4.  Stress and putative endogenous ligands for benzodiazepine receptors: the importance of characteristics of the aversive situation and of differential emotionality in experimental animals.

Authors:  A Fernández-Teruel; R M Escorihuela; A Tobeña; P Driscoll
Journal:  Experientia       Date:  1991-10-15

5.  Anxiolytic effects of Lippia citriodora in a mouce model of anxiety.

Authors:  Atousa Bonyani; Seyed Ebrahim Sajjadi; Mohammad Rabbani
Journal:  Res Pharm Sci       Date:  2018-06

6.  Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

Authors:  Miroslav M Savić; Dragan I Obradović; Nenad D Ugresić; James M Cook; P V V S Sarma; Dubravko R Bokonjić
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

7.  Early developmental exposure to benzodiazepine ligands alters brain levels of thiobarbituric acid-reactive products in young adult rats.

Authors:  R C Miranda; J P Wagner; C K Kellogg
Journal:  Neurochem Res       Date:  1989-11       Impact factor: 3.996

8.  "Anxiolytic" and "anxiogenic" benzodiazepines and beta-carbolines: effects on aggressive and social behavior in rats and squirrel monkeys.

Authors:  E M Weerts; W Tornatzky; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Prevention of the pro-aggressive effects of alcohol in rats and squirrel monkeys by benzodiazepine receptor antagonists.

Authors:  E M Weerts; W Tornatzky; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.

Authors:  J W Mandema; M T Kuck; M Danhof
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.